ChengDa Pharmaceuticals Co. Ltd. (301201) — Cash Flow Quality Index
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Cash Flow Quality Index of 2.11x as of December 2023. Operating cash flow of CN¥192.07 Million exceeds net income of CN¥90.98 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of ChengDa Pharmaceuticals Co. Ltd. to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ChengDa Pharmaceuticals Co. Ltd. Cash Flow Quality Index (2019–2023)
Historical Cash Flow Quality Index for ChengDa Pharmaceuticals Co. Ltd. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 301201 cash generation efficiency.
Annual Cash Flow Quality Index for ChengDa Pharmaceuticals Co. Ltd. (2019–2023)
Year-by-year earnings quality comparison for ChengDa Pharmaceuticals Co. Ltd..
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 2.11x | CN¥192.07 Million | CN¥90.98 Million | ▲ +371.6% |
| 2022 | 0.45x | CN¥47.67 Million | CN¥106.48 Million | ▼ -45.9% |
| 2021 | 0.83x | CN¥83.14 Million | CN¥100.44 Million | ▼ -22.2% |
| 2020 | 1.06x | CN¥128.97 Million | CN¥121.17 Million | ▼ -14.5% |
| 2019 | 1.25x | CN¥67.52 Million | CN¥54.22 Million | — |